Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Cáncer
6
Agentes antineoplásicos
2
Aspectos moleculares
2
Diagnóstico
2
Histopatología
2
Carcinogénesis química
1
Citodiagnóstico
1
Enfermedades
1
Enfermedades de la próstata
1
Enfermería
1
Farmacología
1
Inmunodiagnóstico
1
Mamas
1
Merkel celulas
1
Merkel celulas carcinoma
1
Oncología
1
Patofisiología
1
Próstata
1
Quimioterapia
1
-
148361por Alfano, Massimo, Alchera, Elisa, Sacchi, Angelina, Gori, Alessandro, Quilici, Giacomo, Locatelli, Irene, Venegoni, Chiara, Lucianò, Roberta, Gasparri, Anna Maria, Colombo, Barbara, Taiè, Giulia, Jose, Jithin, Armanetti, Paolo, Menichetti, Luca, Musco, Giovanna, Salonia, Andrea, Corti, Angelo, Curnis, Flavio“…Because current imaging techniques may fail to detect small lesions of in situ carcinomas, patients with bladder cancer often relapse after initial diagnosis, thereby requiring frequent follow-up and treatments. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
148362por Abuei, Haniyeh, Namdari, Sepide, Pakdel, Tahereh, Pakdel, Fatemeh, Andishe-Tadbir, Azadeh, Behzad-Behbahani, Abbas, Ashraf, Mohammad J., Alavi, Parnian, Farhadi, Ali“…BACKGROUND: The role of human parvovirus B19 (B19V) infection in malignant and benign lesions such as head and neck squamous cell carcinomas (HNSCCs) and oral mucocele lesions has not been established. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
148363por Park, Se Jun, Shin, Kabsoo, Hong, Tae Ho, Lee, Sung Hak, Kim, In-Ho, Kim, Younghoon, Lee, MyungAh“…Patients with a histomolecular PB phenotype (CDX2 negative, MUC1 positive, MUC2 negative, and irrespective of the CK20 results) were associated with poor prognostic outcomes in both disease-free survival (DFS) (HR = 1.81; 95% CI, 1.04–3.17; p = 0.054) and overall survival (OS) (HR = 2.01; 95% CI, 1.11–3.66; p = 0.039) compared to those with histomolecular intestinal carcinomas. Patients with the PB subtype were more likely to have local recurrence alone (11 of 37, 29.7%) compared to those with the intestinal subtype (1 of 15, 6.7%). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
148364por Gertsenshteyn, Inna, Epel, Boris, Giurcanu, Mihai, Barth, Eugene, Lukens, John, Hall, Kayla, Martinez, Jenipher Flores, Grana, Mellissa, Maggio, Matthew, Miller, Richard C., Sundramoorthy, Subramanian V., Krzykawska-Serda, Martyna, Pearson, Erik, Aydogan, Bulent, Weichselbaum, Ralph R., Tormyshev, Victor M., Kotecha, Mrignayani, Halpern, Howard J.“…MATERIALS AND METHODS: Three murine tumor models were used for multi-modal imaging and radiotherapy: MCa-4 mammary adenocarcinomas, SCC7 squamous cell carcinomas, and FSa fibrosarcomas. Registered T2-weighted MRI tumor boundaries, hypoxia defined by EPROI as pO(2) ≤ 10 mmHg, and X-RAD 225Cx CT boost boundaries were obtained for all animals. 13 Gy boosts were directed to hypoxic or equal-integral-volume oxygenated tumor regions and monitored for regrowth. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
148365por Weber, Christine A. M., Krönke, Nicole, Volk, Valery, Auber, Bernd, Förster, Alisa, Trost, Detlef, Geffers, Robert, Esmaeilzadeh, Majid, Lalk, Michael, Nabavi, Arya, Samii, Amir, Krauss, Joachim K., Feuerhake, Friedrich, Hartmann, Christian, Wiese, Bettina, Brand, Frank, Weber, Ruthild G.“…Pathogenic germline variants in the DNA polymerase genes POLE and POLD1 cause polymerase proofreading-associated polyposis, a dominantly inherited disorder with increased risk of colorectal carcinomas and other tumors. POLE/POLD1 variants may result in high somatic mutation and neoantigen loads that confer susceptibility to immune checkpoint inhibitors (ICIs). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
148366por Kato, T, Steers, G, Campo, L, Roberts, H, Leek, R D, Turley, H, Kimura, T, Kameoka, S, Nishikawa, T, Kobayashi, M, Harris, A L, Gatter, K C, Pezzella, F“…British patients were significantly older (56.3±11.4 years vs 52.5±12.9 years; P<0.01) and had smaller tumours (2.2±1.3 vs 2.7±1.8 cm; P<0.01), which were more frequently oestrogen receptor positive (78.8 vs 57.2%, P<0.01), had more grade III tumours (29.9 vs 21.4%, P=0.04) and more infiltrating lobular carcinomas (13.6 vs 4.0%, P<0.01) and a higher MVD compared with Japanese patients (57.9±19.8 vs 53.2±18.6; P=0.01). …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
148367“…Two hundred and ninety-seven (84.3%) samples with an atypical squamous cells of undetermined significance or worse result and 100% of those with detection of high-grade squamous intraepithelial lesions and carcinomas (HSIL+) were triaged into the high-score group. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
148368“…The relative efficacy of cytotoxic agents for the treatment of TGCT patients was studied in three different cell lines derived from human embryonal carcinomas (EC) in an in vitro hypoxia model. NT2, 2102 EP, and NCCIT were tested for their sensitivity towards cisplatin, etoposide, bleomycin, 4-OOH-ifosfamide, carboplatin, paclitaxel, gemcitabine, oxaliplatin, irinotecan, and mitomycin C under normoxic and hypoxic conditions using the MTT assay. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
148369“…A total of 67 transitional cell carcinomas of the bladder treated by CRT (median dose: 32.4 Gy of radiation and 232 mg of CDDP) were studied. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
148370“…METHODS: All consecutive EOC patients (n=632) after primary tumour debulking in our institution (09/2000–08/2010) were classified into one of two groups: type I tumours (n=100; 15.8%) composed of low-grade serous, low-grade endometrioid, clear cell, mucinous and transitional carcinomas; and Type II tumours (n=532; 84.1%) composed of high-grade serous, high-grade endometrioid, undifferentiated and malignant mixed-mesodermal tumours. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
148371por Bellone, S, Tassi, R, Betti, M, English, D, Cocco, E, Gasparrini, S, Bortolomai, I, Black, J D, Todeschini, P, Romani, C, Ravaggi, A, Bignotti, E, Bandiera, E, Zanotti, L, Pecorelli, S, Ardighieri, L, Falchetti, M, Donzelli, C, Siegel, E R, Azodi, M, Silasi, D-A, Ratner, E, Schwartz, P E, Rutherford, T J, Santin, A D“…METHODS: We profiled 70 ovarian carcinomas including 24 serous (OSPC), 15 clear-cell (CC), 24 endometrioid (EAC) and 7 poorly differentiated tumours, and 14 normal human ovarian surface epithelial (HOSE) control cell lines using the Human HG-U133 Plus 2.0 chip (Affymetrix). …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
148372por Welsh, Liam, Panek, Rafal, McQuaid, Dualta, Dunlop, Alex, Schmidt, Maria, Riddell, Angela, Koh, Dow-Mu, Doran, Simon, Murray, Iain, Du, Yong, Chua, Sue, Hansen, Vibeke, Wong, Kee H., Dean, Jamie, Gulliford, Sarah, Bhide, Shreerang, Leach, Martin O., Nutting, Christopher, Harrington, Kevin, Newbold, Kate“…METHODS/DESIGN: The INSIGHT study is a single-centre, prospective, longitudinal multi-modality imaging study using functional MRI and FDG-PET/CT for patients with LAHNC squamous cell carcinomas receiving radical CRT. Two cohorts of patients are being recruited: one treated with, and another treated without, induction chemotherapy. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
148373por Lin, C-C, Sharma, S B, Farrugia, M K, McLaughlin, S L, Ice, R J, Loskutov, Y V, Pugacheva, E N, Brundage, K M, Chen, D, Ruppert, J M“…In this study, we found that both KLF4 and a downstream effector, microRNA-206 (miR-206), are selectively enriched in the MaCSC fractions of cultured human TNBC cell lines, as well as in the aldehyde dehydrogenase-high MaCSC sub-population of cells derived from xenografted human mammary carcinomas. The suppression of endogenous KLF4 or miR-206 activities abrogated cell survival and in vivo tumor initiation, despite having only subtle effects on MaCSC abundance. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
148374por Graham, J. S., Boyd, K., Coxon, F. Y., Wall, L. R., Eatock, M. M., Maughan, T. S., Highley, M., Soulis, E., Harden, S., Bützberger-Zimmerli, P., Evans, T. R. J.“…BACKGROUND: Advanced biliary tract carcinomas are associated with a poor prognosis, and palliative chemotherapy has only modest benefit. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
148375por Aoyama, Ikuo, Ohashi, Shinya, Amanuma, Yusuke, Hirohashi, Kenshiro, Mizumoto, Ayaka, Funakoshi, Makiko, Tsurumaki, Mihoko, Nakai, Yukie, Tanaka, Katsuyuki, Hanada, Mariko, Uesaka, Aki, Chiba, Tsutomu, Muto, Manabu“…Many epidemiological studies have reported that ALDH2*2 carriers are at high risk for esophageal or head and neck squamous cell carcinomas by habitual drinking. Therefore, identification of ALDH2*2 carriers would be helpful for the prevention of those cancers, but there have been no methods suitable for mass screening to identify these individuals. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
148376por Kamieniak, Marta M., Rico, Daniel, Milne, Roger L., Muñoz-Repeto, Ivan, Ibáñez, Kristina, Grillo, Miguel A., Domingo, Samuel, Borrego, Salud, Cazorla, Alicia, García-Bueno, José M., Hernando, Susana, García-Donas, Jesús, Hernández-Agudo, Elena, y Cajal, Teresa Ramón, Robles-Díaz, Luis, Márquez-Rodas, Ivan, Cusidó, Maite, Sáez, Raquel, Lacambra-Calvet, Carmen, Osorio, Ana, Urioste, Miguel, Cigudosa, Juan C., Paz-Ares, Luis, Palacios, José, Benítez, Javier, García, María J.“…Standard treatments for advanced high‐grade serous ovarian carcinomas (HGSOCs) show significant side‐effects and provide only short‐term survival benefits due to disease recurrence. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
148377por Iotti, Valentina, Ravaioli, Sara, Vacondio, Rita, Coriani, Chiara, Caffarri, Sabrina, Sghedoni, Roberto, Nitrosi, Andrea, Ragazzi, Moira, Gasparini, Elisa, Masini, Cristina, Bisagni, Giancarlo, Falco, Giuseppe, Ferrari, Guglielmo, Braglia, Luca, Del Prato, Alberto, Malavolti, Ivana, Ginocchi, Vladimiro, Pattacini, Pierpaolo“…BACKGROUND: Neoadjuvant-chemotherapy (NAC) is considered the standard treatment for locally advanced breast carcinomas. Accurate assessment of disease response is fundamental to increase the chances of successful breast-conserving surgery and to avoid local recurrence. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
148378por Qiao, Lijun, Zheng, Jingyi, Tian, Yonghao, Zhang, Qishu, Wang, Xiao, Chen, Jason J., Zhang, Weifang“…Furthermore, little is known about the relationship between RCC1 and carcinomas. Human papillomavirus (HPV) infection is highly associated with the development of cervical cancer. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
148379por Gu, Yu-Lin, Gu, Wei-Jun, Dou, Jing-Tao, Lv, Zhao-Hui, Li, Jie, Zhang, Sai-Chun, Yang, Guo-Qing, Guo, Qing-Hua, Ba, Jian-Ming, Zang, Li, Jin, Nan, Du, Jin, Pei, Yu, Mu, Yi-Ming“…Its common causes include primary pigmented nodular adrenocortical disease, ACTH-independent macronodular adrenal hyperplasia, and bilateral adrenocortical adenomas (BAAs) or carcinomas. BAAs causing ACTH-independent CS are rare; up to now, fewer than 40 BAA cases have been reported. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
148380por O’Malley, Dennis P., Yang, Yuhang, Boisot, Saskia, Sudarsanam, Sucha, Wang, Jian-Feng, Chizhevsky, Vladislav, Zhao, Guohua, Arain, Shehla, Weiss, Lawrence M.“…We found broad ranges of expression in tumor types with increasing positivity, as adenocarcinomas were reported as poorly differentiated, whereas squamous cell carcinomas showed more positivity as tumors were described as well-differentiated. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto